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Biodegradable materials are materials that degrade (decompose) in a bioiogical
environment. In the medical field they have been used for nearly 4o years in sutures and
osteosynthesis materials. As a result oftheir degradability these devices do not have to be
removed from the body after they have performed their function.
Nowadays, biodegradable materials are also applied in regenerative medicine. In this
application, scaffolds made of biodegradable materials are used to engineer tissue outside
the body or to guide regeneration of damaged tissue inside the body.
Most biodegradable materiais are polymers. Amorphous copolymers of lactic acid and
other monomers with an equivalent structure have proven to be most biocompatible, both
initially and during degradation. The application of these copolymers is restricted, mainly
as a result of their limited elastic and mechanical properties. These polyesters can be
reinforced by connecting the polyester chains with degradable urethane segments, which
results in biodegradable polyurethanes.
Until recently biodegradable poiyurethanes were produced using aromatic diisocyanates.
The degradation ofthese polyurethanes Ieads to the release ofpotentially carcinogenic
components. The polyurethanes that were investigated in this thesis were synthesized
from an aliphatic diisoryanate. The material consists of repeating units of hard urethane
segments and amorphous soft segments based on a copolyester of Dl-lactide and e -
caprolactone.
The urethane segments have a uniform length of five urethane moieties and are
synthesized from r,4-butanediisocyanate and butanediol. During degradation ofthe
urethane segments butanediamine is formed. Butanediamine is normally present in the
human body and can be excreted with the urine.
Before a new biodegradable material can be used safely and effectively in medical
applications everai aspects of biodegradation and biocompatibility have to be investigated.
These include biocompatibility of the non-degraded material, biocompatibility during
degradation and finally total resorption of the material. Depending on the application of
the material other aspects have to be tested as well, such as the degradation at a specific
anatomical location (Chapter r).
In this thesis highly porous foams of the polyurethane based on r,4-butanediisocyanate
were investigated. Because of the good mechanical and elastic properties the foam is a
serious candidate for use in tissue regeneration applications. The performance ofthe foam
in a biological environment had not been extensively investigated before the start ofthis
research project. Therefore, several invivo andinvitro biocompatibility and degradation
experiments were performed to investigate the possibility of using the foams in medical
devices for tissue regeneration.
In all biocompatibility and degradation studies (Chapter z-5) the polyurethane foams
were compared to high molecular weight copolymer foams made of Dl-lactide and
e-caprolactone. This is a polyester of similar components as the soft segments of the
polyurethane. The biocompatibility and biodegradation of this reference material has been
extensively investigated.
The polyurethane foams were also tested in a specific application, that is the closure of
oroantral communications. An oroantral communication is an open connection between
the oral cavity and the maxillary sinus. This defect is mostly caused by extraction of
(pre)molars from the maxilla. As a rule oroantral communications are closed surgically.
the defect with the biodegradable polyurethane foam. It is assumed that the good elastic
properties of the polyurethane keep the foam in place while the oral and maxillary sinus
mucosa are healing.
Before research into the application started several aspects ofthe short-term biocomp-
atibility of the polyurethane foam were evaluated (Chapter z).
The in vitro rytotoxicity of the non-degraded foam was established first. Fibroblasts
were cultured and were either directly exposed to the polyurethane or exposed to extracts
of the material. After incubation periods of z4 ïo 7z hours the rytotoxicity was evaluated
by counting the cells, by measuring their metabolic activity, and by a morphological
evaluation. In these tests the polyurethane caused no abnormal growth behaviour, nor
morphological changes or inhibition in metabolic activity.
To establish ïhe in vivo biocompatibility of the non-degraded polyurethane small foam
discs were implanted subcutaneously on the back of rats for one, four and twelve weeks.
The tissue response to the material was histologically evaluated. These studies did not
show any toxic tissue response to the polyurethane. The foams provided an inviting matrix
for connective tissue ingrowth, accompanied by vascular ingrowth. From these short-
term experiments it was concluded that the non-degraded polyurethane shows a good
biocompatibility, both in vitro and in vivo.
Most problems regarding the biocompatibility of biodegradable polymers occur after
longer periods of implantation. Nowadays, nearly all investigations into the long-term
safety of biodegradable materials are stiil being performed with animal experiments.
In Chapter 3 a new method is proposed to test the long-term in vitro c)'totoxicity of
biodegradable materials by testing the toxicity oftheir degradation products. The study
was performed to develop a method that saves time, Iaboratory animals and research
funds. The biodegradable polyurethane foam and the copolymer control material were
subjected to this new test method.
Accumulated degradation products of the materials were collected by degrading the
foams in distilled water at 6o'C up to 5z weeks. Cell culture medium was prepared from
powder medium using this water. In several tests, comparable to the methods of Chapter
z, the rytotoxicity of this medium was established.
The first signs of cytotoxicity were observed after 3 to 5 weeks degradation. This
accounted for both materials and re-established the good short-term biocompatibility of
the polyurethane and the reference material.
The polyurethane showed more toxicity towards the end stages of degradation in
comparison with the copolymer control. This is probably related to the accumulation of
degradation products of the urethane segments. It was speculated that the mechanisms for
metabolism and excretion of these degradation products, which are available inthe invivo
situation, prevent toxic reactions in vivo.
In Chapter 4 the degradation ofthe highly porous polyurethane and copolymer control
foams was evaluated invitro. The foams were degraded in a Sórensen buffer solution
(pH l.D at 37'C and 6ooC for time intervals up to 3 years. The remaining material was
coilected on microporous filters. Dimensions of the foams, intrinsic viscosity, mass loss,
thermal properties and composition of the remaining material were evaluated.
The polyurethane foams kept their dimensions for zo weeks at 37"C. The copolymer
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foams collapsed after 3 weeks and lost 6oolo f their volume. PU mass loss reached a
maximum of 8oo/o at both 37'C and 6o"C. CP mass loss reached 99.9o/o aï6o"C, andgzo/o
aï 37'C after 3 years.
Analysis of the 37'C and 6ooC results showed that the degradation processes are initially
the same, but eventually degradation products with different thermal properties are being
formed. 'H-NMR studies showed that the hard urethane segments of the PU do not
degrade invitro.
It was concluded that the polyurethane material has favourable characteristics for a
scaffold material. Total resorption, however, can still be best investigated with in vivo
studies. These were described in Chapter 5.
In a long-term subcutaneous implantation study polyurethane foam discs were
implanted in rats and rabbits for intervals up to 3 years. The copolymer foam of Dl-lactide
and e-caprolactone served again as a control. The foams and surrounding tissues were
evaluated with light and transmission electron microscopy, with respect o tissue response
during degradation and, ultimately, the resorption of the material. At later stages of
degradation lymph nodes draining the implantation sites were evaluated for the presence
of remnants of the polyurethane.
During degradation, temporary elevated numbers of macrophages and giant cells
were observed in both the polyurethane and the control samples. Electron microscopy
showed that the macrophages contained pieces ofthe polyurethane. The size ofthe
intracellular polyurethane particles diminished and the cells containing these remnants
gradually disappeared after periods from r to 3 years. After 3 years an occasional isolated
macrophage with biomaterial remnants could be traced in both the polyurethane and
the copolymer explants. A few macrophages with biomaterial remnants were temporary
observed in the lymph nodes in the periods between 39 weeks and t.5 years.
It was concluded that the PU foam is biocompatible during degradation. After 3 years
PU samples had been resorbed almost completely. Based on the results, local intracellular
degradation, followed by removal of the low molecular degradation products through
the blood stream seems the most likely route of elimination of the material. The results
indicate that the PU foam can be safely used as a biodegradable implant. They also
indicate that the in vitro results of Chapter 4 are only partly representative for ïhe in vivo
situation and therefore total resorption has to be investigated in long-term invivo studies.
Before a medical device can be applied in humans, the application shouid be tested in
animal experiments. For the investigations into the closure of oroantral communications
(OACs) animal models were not readily available. In Chapter 6 a pilot study was
performed to investigate whether the Góttingen minipig is a suitable animal model for
creating and closing OACs. The application of the polyurethane foam in the defects was
tested as well. In three adult minipigs the left and right second maxiilary molars were
extracted. An OAC was created by drilling from the extraction socket to the maxillary sinus.
The left side was closed by a standard surgical buccal flap procedure, which is comparable
to the surgical closure performed in humans. The right defects were treated by applying
the biodegradable polyurethane foam. After z weeks, t month and 3 months the pigs were
sacrificed for histological evaluation.
Postmortal and histological examination showed that an OAC was created only in one
ofsix cases. In the remaining cases the infraorbital canal was perforated instead ofthe
floor of the maxillary sinus. It was concluded Góttingen minipig is not a suitable animal
model, due to the location of the infraorbital nerve. As a result the closure of the OACs
with the biodegradable polyurethane foam could not be evaluated. The first observations of
the polyurethane implanted in the maxilla showed a mild tissue response to the material.
There were aiso some indications that the oral mucosa could not grow rapidly across the
foam.
In Chapter 7 another pilot study is described. In that study the suitability of rabbits to
serve as an animal model for the closure of OACs was investigated. Six rabbits were used,
and an OAC was created on both sides of the maxilla. Three rabbits were used to evaluate
the animal model by applying a surgical treatment on one side and by leaving the other
defects untreated. The results were evaluated after r, z and 4 weeks of healing. Histological
evaluation showed that OACs had been created in the rabbits. The surgically treated defects
healed without complications. The untreated defects showed complicated and delayed
healing. It was therefore concluded that the rabbit is a suitable animal model.
In the three other rabbits OACs were closed with poiyurethane foam. Based on the
results of chapter 6 some modifications in the composition of the soft segment of the
polyurethane were introduced. The polyurethane with the 'standard' composition of the
soft segments (Dl-lactide and e-caprolactone) was used to close half of the defects. The
other defects were closed with a polyurethane to which z3olo polyethylene glycol was added
to a glycolide./e-caprolactone soft segment to make the material more hydrophilic.
Although closure of the OAC was achieved, the foam with z3olo polyethylene glycol
degraded too fast for our purpose. Just as in the minipigs, the standard polyurethane did
not guide the regeneration of the oral mucosa very well.
In Chapter 8 a PU with an intermediate composition, with 5olo polyethylene glycol added
to the Dl-lactide/e-caprolactone soft segment, was used to close OACs in rabbits. Nine
rabbits were used and an OAC was created on both sides of the maxilla. In this experiment
standard surgical closure was compared to closure with the polyurethane foam. Heaiing of
the defects was evaluated by clinical and histological examination, after periods from t, z,
a. and ro weeks.
The surgically treated defects healed uneventfully. The oral side ofthe foam treated
defects had clinically closed after 4 weeks. Some of the foams occupied a relatively large
part of the small maxillary sinus. Nevertheless, the maxillary sinus mucosa gradually grew
across the polyurethane foams. Regeneration of maxillary bone was observed in both the
foam-treated defects and the surgical control. It was concluded that the polyurethane
foam with 5olo polyethyleneglycol provides adequate closure of an OAC in the rabbit animal
model to allow healing of the defect.
In Chapter 9 the results of the former chapters are compared and discussed.
Because of the limitati ons of in vitro experiments (Chapter 2,3 and 4) ïhe in vivo
experiments (Chapter z and 5) can still be considered as 'the golden standard'. Based
on the ln vívo experíments it was concluded that the polyurethane shows a satisfactory
biocompatibility, both initially and during degradation. After three years the foams are
at the end stage of degradation. The observations with the electron microscope indicate
that the resorption has not stopped and it is very likely that the materiai will ultimately be
totaliy resorbed.
The investigation into the closure of oroantral communications has been performed
in a relatively small number of animals. Nevertheless, this treatment method can now
be tested in long-term animal experiments with a polyurethane \4/ith a degradation rate
and hydrophilicity that is modified according to the needs of the application. The very
satisfactory results of the biocompatibility and biodegradation experiments even make it
possible to introduce the material in human studies in the near future.
